- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Arena Pharmaceuticals Inc
Add to PortfolioARNA:US
6.0000 USD 0.0400 0.66%As of 20:10:00 ET on 05/25/2012.
Snapshot for Arena Pharmaceuticals Inc (ARNA)
| Open: | 5.9900 | Day's Range: | 5.8800 - 6.0500 | Volume: | 6,627,182 | Bid: | 5.9900 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 6.0400 | 52wk Range: | 1.2300 - 7.0150 | 1-Yr Rtn: | +308.16% | Ask: | 6.0000 |
Key Statistics for ARNA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.6500 |
| Est. EPS (USD) (12/2012) | -0.4510 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,173.00 |
| Shares Outstanding (M) | 195.50 |
| Enterprise Value (M USD) (ttm) | 1,172.48 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 24.4279 |
| Price/Sale (ttm) | 80.9898 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/09/2012 |
More ARNA Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ARNA
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for ARNA
Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.
| Jack LiefChairman/President/CEO | Robert E HoffmanVP:Finance/CFO |
| Dominic P BehanSenior VP/Chief Scientific Ofr | William R Shanahan JrSenior VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page